Solid Biosciences
SLDB
69 hedge funds and large institutions have $88.5M invested in Solid Biosciences in 2019 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 26 increasing their positions, 14 reducing their positions, and 17 closing their positions.
86% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 14
24% more call options, than puts
Call options by funds: $3.36M | Put options by funds: $2.71M
0% more funds holding
Funds holding: 69 → 69 (0)
0% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 17
1.77% less ownership
Funds ownership: 4.65% → 2.88% (-1.8%)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
73% less capital invested
Capital invested by funds: $332M → $88.5M (-$244M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$2.49M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.43M |
| 3 |
Morgan Stanley
New York
|
+$2.39M |
| 4 |
BlackRock
New York
|
+$1.69M |
| 5 |
D.E. Shaw & Co
New York
|
+$1.38M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$69.8M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
-$34.6M |
| 3 |
BC
Boxer Capital
San Diego,
California
|
-$21.1M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$5.09M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.29M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GTC
76
Ghost Tree Capital
New York
| – | -$1.03M | -6,667 | Closed |
|
77
Invesco
Atlanta,
Georgia
| – | -$834K | -5,379 | Closed |
|
|
DC
78
Diametric Capital
Boston,
Massachusetts
| – | -$201K | -1,294 | Closed |
|
|
PPA
79
Parametric Portfolio Associates
Seattle,
Washington
| – | -$200K | -1,290 | Closed |
|
80
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| – | -$132K | -818 | Closed |
|
|
PCM
81
Prelude Capital Management
New York
| – | -$122K | -788 | Closed |
|
|
CIAS
82
Capital Investment Advisory Services
Raleigh,
North Carolina
| – | -$23K | -147 | Closed |
|
83
First Manhattan
New York
| – | -$20K | -133 | Closed |
|
84
Victory Capital Management
San Antonio,
Texas
| – | -$19K | -123 | Closed |
|
|
LTFS
85
Ladenburg Thalmann Financial Services
Miami,
Florida
| – | -$10K | -67 | Closed |
|
|
QT
86
Quantamental Technologies
White Plains,
New York
| – | -$8K | -50 | Closed |
|
SLDB Hedge Fund Activity: Q4 2019 in Review
69 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Solid Biosciences (SLDB) for Q4 2019, worth a combined $88.5M — down 73% from $332M a quarter earlier.
Fund positioning in SLDB was balanced in Q4 2019: 17 funds opened new positions, 17 closed out, 26 added to existing stakes and 14 trimmed.
The largest buyer was Millennium Management, adding an estimated $2.49M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $69.8M sold.
- 69 institutional investors held Solid Biosciences (SLDB) as of Q4 2019, unchanged from Q3 2019.
- Funds reported $88.5M of Solid Biosciences stock for Q4 2019, down 73% quarter-over-quarter.
- 17 funds opened new Solid Biosciences positions in Q4 2019 and 17 closed out, a net change of 0 holders.
- The largest Solid Biosciences buyer in Q4 2019 was Millennium Management, an estimated $2.49M added.
- The largest Solid Biosciences seller in Q4 2019 was Perceptive Advisors, an estimated $69.8M sold.
Based on aggregated 13F filings for Q4 2019.